<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032017000300189</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Hallazgos inmunohistoquímicos en una muestra de pacientes con cáncer de mama atendidos del 2009 al 2013 en el Hospital Ángeles Pedregal]]></article-title>
<article-title xml:lang="en"><![CDATA[Immunohistochemical findings in a sample of patients with breast cancer treated from 2009 to 2013 at the Hospital Angeles Pedregal]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Álvarez]]></surname>
<given-names><![CDATA[Consuelo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Romo Aguirre]]></surname>
<given-names><![CDATA[Catalina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Clemenceau V]]></surname>
<given-names><![CDATA[Jean René]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valenzuela Tamariz]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ayala Pacheco]]></surname>
<given-names><![CDATA[Blanca Fátima]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad La Salle Facultad Mexicana de Medicina Hospital Ángeles Pedregal]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Ángeles Pedregal  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Ángeles Pedregal Centro de Cáncer ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital Ángeles Pedregal Departamento de Patología ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2017</year>
</pub-date>
<volume>15</volume>
<numero>3</numero>
<fpage>189</fpage>
<lpage>193</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032017000300189&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032017000300189&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032017000300189&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción: El cáncer de mama es la primera causa de muerte en la mujer en México. Es una enfermedad heterogénea que demanda un abordaje multidisciplinario, con el sustento tecnológico adecuado a fin de implementar mejores estrategias terapéuticas. Con base en su clasificación y grado de malignidad, se debe definir el pronóstico y tratamiento, lo que a su vez logrará favorecer la calidad de vida y la supervivencia.  Objetivo:  Determinar las características inmunohistoquímicas de una muestra de pacientes con diagnóstico de cáncer de mama que acudieron al Hospital Ángeles Pedregal del 2009 al 2013.  Material y métodos: Estudio descriptivo, retrolectivo, longitudinal, en el cual se analizaron expedientes clínicos y resultados de histopatología; la muestra total fue de 417 pacientes durante el periodo de enero de 2009 a diciembre de 2013.  Resultados: Se analizaron 417 casos, de los cuales el principal tipo histopatológico encontrado fue: ductal infiltrante sin patrón específico (71.94%). El tratamiento quirúrgico conservador se realizó en 25% mientras que el radical en 37%.  Conclusiones: Este estudio mostró una diferencia en la edad media de diagnóstico (56 años ± 13), en comparación con el promedio nacional de 60. La mortalidad fue de 1.9%, por debajo del promedio nacional.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction: Breast cancer is the leading cause of death in women in Mexico, and this is a heterogeneous disease, which requires a multidisciplinary approach, with the appropriate technological support to implement therapeutic strategies based on their classification and degree of malignancy which could inference of the prognosis and treatment, as well as in the patients with advanced disease could promote the quality of life and survival.  Objective: Determine the characteristics, surgical, histopathology and immunohistochemical of patients with a diagnosis of Breast Cancer at the Hospital Ángeles Pedregal.  Material and methods:  We realize a retrospective, descriptive, longitudinal study, where 417 clinical records and histopathological reports were analyzed during the period from January 2009 to December 2013.  Results:  We obtained from the 417 cases that the main histopathological type was the ductal infiltrating carcinoma with 71.94%. Surgical conservative treatment was conducted in a 25% while radical treatment was made in 37%. The Mortality rate was 1.9% which results below the national average.  Conclusions:  It is essential to recognize that the morbidity of this pathology is duly detectable and close monitoring is essential to improve the quality of life of the patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cáncer de mama]]></kwd>
<kwd lng="es"><![CDATA[inmunohistoquímica]]></kwd>
<kwd lng="es"><![CDATA[histopatológico]]></kwd>
<kwd lng="en"><![CDATA[Breast cancer]]></kwd>
<kwd lng="en"><![CDATA[inmunohistochemical]]></kwd>
<kwd lng="en"><![CDATA[histopathology]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Performance and reporting of clinical breast examination a review of the literature]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDonald]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Saslow]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Alciati]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2004</year>
<volume>54</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>345-61</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Efficiency of palpation in clinical detection of breast cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahoney]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Csima]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Can Med Assoc J]]></source>
<year>1982</year>
<volume>127</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>729-30</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Core biopsy versus FNAC for palpable breast cancers Is image guidance necessary?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agarwal]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rajan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Darzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hadjiminas]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Cancer]]></source>
<year>2003</year>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>52-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diagnóstico histopatológico y factores pronósticos en cáncer infiltrante de la glándula mamaria]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Sánchez]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Vela-Chávez]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Mora-Tiscareño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancerología]]></source>
<year>2008</year>
<volume>3</volume>
<page-range>7-17</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sørlie]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Perou]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Tibshirani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Aas]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Geisler]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Johnsen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Proc Natl Acad Sci U S A]]></source>
<year>2001</year>
<volume>98</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>10869-74</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[MammaPrint 70-gene signature another milestone in personalized medical care for breast cancer patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Slodkowska]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<source><![CDATA[Expert Rev Mol Diagn]]></source>
<year>2009</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>417-22</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albain]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Paik]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[van't Veer]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Breast]]></source>
<year>2009</year>
<volume>18</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>S141-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cáncer de mama]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huicochea-Castellanos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[González-Balboa]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tovar-Calderón]]></surname>
<given-names><![CDATA[IL]]></given-names>
</name>
<name>
<surname><![CDATA[Olarte-Casas]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez-Lamadrid]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Anales de Radiología México]]></source>
<year>2009</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>117-26</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Genética del cáncer de mama aplicaciones para la población mexicana]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ziv]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Salud Pública Mex]]></source>
<year>2011</year>
<volume>53</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>415-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Estrogen and progesterone receptors in human breast cancer Correlation with histologic subtype and degree of differentiation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohammed]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Lakatua]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Haus]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yasmineh]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer]]></source>
<year>1986</year>
<volume>58</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1076-81</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cáncer de mama en México: tendencia en los últimos 10 años de la incidencia y edad al diagnóstico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salinas-Martínez]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Juárez-Ruiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mathiew-Quirós]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán-De la Garza]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Santos-Lartigue]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar-Moreno]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Invest Clin]]></source>
<year>2014</year>
<volume>66</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>210-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cáncer de mama en el Instituto Nacional de Cancerología Experiencia del Seguro Popular 2007-2013]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reynoso]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Villarreal-Garza]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bargalló-Rocha]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Arce-Salinas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lara-Medina]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Mex Mastol]]></source>
<year>2015</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-11</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
